AARNet

AARNet is Australia’s national research and education network, a not-for-profit organisation equally owned by 38 Australian universities and CSIRO. AARNet provides essential high-speed internet and advanced network services tailored to meet the specialised needs of researchers in Australia.

First in-human images of new hope treatment for poor-prognosis prostate cancer

In a world first, supported by National Imaging Facility, Australian researchers have imaged and measured the uptake of a promising new prostate cancer therapy drug developed by Australian company AdvanCell, which was recently administered to its first patient in a clinical trial. Prostate cancer is the second most common cancer for men. Around 50% of […]

New brain imaging set to improve and speed epilepsy diagnosis, treatment

Novel imaging methods combined with cognitive, genetic and medical data will use AI to increase the speed and accuracy of diagnoses and treatment for epilepsy patients, according to researchers working collaboratively with NIF. Advanced MRI imaging methods are helping Australian epilepsy researchers move closer to faster, more accurate, individualised diagnoses and treatment options for patients. […]

Future-proofing computational proteomics

EMBL Australia and Bioplatforms Australia joined forces to host a pivotal proteomics workshop titled ‘Future-proofing Computational Proteomics’ on 24 April, featuring leading guest speakers, Dr Rolf Apweiler, Prof Marc Wilkins and Dr Richard Lipscombe. The Australian proteomics community discussed advancements in proteomics research and the pivotal role of computational approaches in shaping the future of […]

Therapeutic Innovation Australia (TIA)

Therapeutic Innovation Australia (TIA) is the lead agent for the NCRIS “Therapeutic Innovation Australia” project. TIA a national consortium of translational research infrastructure that provides researchers and SMEs the expertise and capabilities required to move a potential therapeutic product along the development pathway.

Australian Research Data Commons (ARDC)

The Australian Research Data Commons (ARDC) provides Australian researchers with competitive advantage through data. It accelerates research and innovation by driving excellence in the creation, analysis and retention of high-quality data assets. The ARDC is enabled by the National Collaborative Research Infrastructure Strategy (NCRIS). NCRIS is a national network of world-class research infrastructure projects that support high-quality research that will drive greater innovation in the Australian research sector and the economy more broadly.

National Imaging Facility (NIF)

National Imaging Facility (NIF) is Australia’s advanced imaging network. We provide open access to world-class imaging equipment, expertise, tools, data and analysis. We address Australia’s strategic science and research priorities, and this benefits Australian industry and helps keep Australians healthy.

Australian Access Federation (AAF)

The Australian Access Federation (AAF) is Australia’s leading provider of identity and access management services to the education and research sector. We make it easy for people to securely access education and research services nationally and internationally, by providing single sign-on. It allows individuals from different organisations to collaborate and access online resources within a trusted environment.

Pawsey Supercomputing Research Centre (Pawsey)

Pawsey Supercomputing Research Centre, Australia’s leading Tier-1 high-performance computing facility, is advancing research and innovation by providing cutting-edge supercomputing, data and visualisation infrastructure and expertise. From accelerating breakthroughs in medicine and climate science to unlocking the mysteries of the universe, Pawsey is at the forefront of driving discovery and advancing knowledge.

Population Health Research Network (PHRN)

The Population Health Research Network (PHRN) has been at the forefront of integrating health and human services data across Australia. With a robust network of data linkage units, PHRN empowers researchers to unlock insights into disease, shaping innovative treatments and enhancing health services nationwide. Underpinned by a commitment to privacy and ethical standards, PHRN exemplifies collaborative research, bolstered by substantial support from government and academic sectors.

Phenomics Australia (PA)

Phenomics Australia provides a national capability to explore the human genome and the genetic basis of health and disease. Our openly accessible service delivery centres span twenty locations across Australia. Through these, we offer specialised infrastructure, research services and technical expertise dedicated to advancing our fundamental understanding of health and disease and enabling next-generation innovations in healthcare and therapeutic development to benefit all Australians.

Microscopy Australia (MicroAu)

Microscopy Australia provides researchers and industry with open access to the nation’s largest range of high-end microscopes, microanalysis tools, and specialists. It consists of university-based microscopy centres around the country. Our instruments have dedicated experts to deliver high quality training and support to ensure you get the best research outcomes.

Protein discovery for better bowel cancer treatments

Bowel cancer claims more than 100 lives in Australia every week. Thankfully, researchers at the Australian National University (ANU) have discovered that an immune protein can slow the division of bowel cancer cells. This is a promising target for both early detection tests and bowel cancer treatments. DR ABHIMANU PANDEY SAYS AN IMMUNE SYSTEM PROTEIN […]

Strengthening our European connections to EMBL and beyond

On a recent visit to EMBL Heidelberg, Ian Smith, Chair of the EMBL Australia Council, spoke about the synergies between EMBL and EMBL Australia, opportunities for collaboration and ideas for exciting future programs. Ian Smith, Chair of the EMBL Australia Council, chatted to EMBL about the synergies between the organisations, opportunities for collaboration, and ideas […]

Clinical Trial Data Unlocked for Research with New National Platform

Health Data Australia is unlocking clinical trial data for research at a national scale. For the first time in Australia, researchers can find clinical trial data from multiple research institutions and request access to it via a new platform, Health Data Australia.  Launching tomorrow at SAHMRI in Adelaide, Health Data Australia allows clinical trialists and data […]

Vaccine patch delivers protection from dengue in mice

Dengue is the most significant mosquito-borne viral disease in the world. With an estimated 390 million cases annually, it results in approximately US$6.9 billion in economic losses. Now Dr David Muller and the vaccine team at the University of Queensland (UQ) have developed a promising dengue vaccine candidate that provides strong immunity in mice when […]

Renewable, versatile spinifex and the future of nanofibres

Spinifex cellulose nanofibres (AIBN)

From nanotechnology to Indigenous empowerment Spinifex, a hardy Australian grass, spread widely across inland Australia, presents a new high-tech opportunity for the future of construction, medical technology, and day-to-day life. In partnership with the Indjalandji-Dhidhanu People of North-West Queensland, through Bulugudu Ltd, researchers at the University of Queensland have been developing a high-tech product from […]

Biobanks: the Australian Phenome Bank

The Australian Phenome Bank: a national biobank and database aiding the discovery of genetic disease causes and advancing Personalised Medicine. Phenomics Australia’s Biobanking service provides a database and cryobank of mouse sperm and embryos essential for discovering and distributing disease models in Australia. The challenge: Ensuring the ongoing availability of mouse strains preserving the investment made in […]

CRISPR/Cas as diagnostics tools

doctor using tablet to review health data

Phenomics Australia NCRIS expertise is used in providing knowledge to look into the commercial and translational potential of CRISPR technology. Phenomics Australia’s long-term support of the In vivo Genome Engineering and Disease Modelling nodes over the years has allowed researchers at the Melbourne Advanced Genome Editing Center (MAGEC) to have a solid understanding of CRISPR/Cas […]

When food kills

Infrastructure and expertise supported by Phenomics Australia and Therapeutic Innovation Australia (TIA)are used in fighting food poisoning toxins. Prof Si Ming Man (right) and Dr Anukriti Mathur (left). Image Lannon Harley/ANU The challenge: Food poisoning is estimated to affect more than 4 million Australians every year – costing the economy $1.25 billion, and in some […]

How Australia’s national research infrastructure is responding to COVID-19

NCRIS COVID-19 response

Australia’s National Research Infrastructure (NRI) swiftly redeployed to support national and international COVID-19 research. Some examples are listed below. Australian Centre for Disease Preparedness (ACDP), Bioplatforms Australia (BPA), Microscopy Australia and Therapautic Innovation Australia (TIA) were involved in the University of Queensland vaccine program. Australian Plant Phenomics Facility (APPF) is supporting research into plant-based vaccines. Astronomy Australia […]

From ancient grass to modern materials

DUGALUNJI ABORIGINAL CORPORATION EMPLOYEES HARVEST SPINIFEX GRASS, CAMOOWEAL, QLD

A unique partnership between Dugalunji Aboriginal Corporation and a University of Queensland research team has lead to the development of valuable and sustainable nanofibres leading to the creation of regional, Indigenous jobs. Challenge Nanofibres can strengthen many materials for a wide range of applications from thinner more flexible electronics and plastics, to next generation building […]

Better cholesterol imaging

NANOSIMS IMAGE OF CHOLESTEROL

An international team of researchers has developed a new way to localise cholesterol is in cells and tissues. This provides insights into how cholesterol moves in and out of cells and could eventually lead to new therapies for cardiovascular disease. Deuterated cholesterol enabled by the National Deuteration Facility and NanoSIMS (nano-Secondary Ion Mass Spectroscopy) at […]